High-Yield LeukoCore™ Osteoarthritis Leukopak for Immunology Research

LeukoCore™ Osteoarthritis Human Leukopak is collected from donors clinically diagnosed with osteoarthritis through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for studying inflammation and immune response that contribute to cartilage degradation and joint damage in osteoarthritis.

Product Features

• Research Use Only (RUO) human leukopaks
• Clinically confirmed osteoarthritis donors
• High cell yield for large-scale studies
• Processed and shipped within 24 hours of collection
• Fresh or cryopreserved options available
• IRB-approved and ethically sourced
• Infectious disease testing
• HLA-A typing
• Screen donors with LeukoLot™

Donor Metadata

• Verified Osteoarthritis diagnosis from healthcare providers
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported medication history and allergies
• Relevant clinical data

Applications

• Immune cell characterization in osteoarthritis
• Therapeutic development and screening
• Cell-based assays and cytokine profiling
• Multi-omics studies including single-cell sequencing

Compliance and Quality Assurance

• Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
• HIPAA-compliant handling of donor information
• Rigorous donor screening and documentation

Ordering & Customization

Osteoarthritis Leukopak is available fresh or cryopreserved. For international shipping or regulatory documentation, please contact to confirm regional compliance and shipping availability.